eCTD format only!
From 1 January 2020
eRA 2019 conference
May 22-23, 2019, Munich, Germany


From a small consulting business Rephine Balticum has grown to an international corporation and has a new division –  Inpharmatis.

Inpharmatis offer comprehensive regulatory affairs services to Life Science Industry including Drug Development and Vigilance Services to pharmaceutical, medical device, food supplements, cosmetic and biotech companies. Our area of expertise lies in the European & CIS market.

A multi-disciplinary team of qualified regulatory affairs consultants is at your disposal for all aspects of your marketing authorisation applications for active substances and human medicinal products. Inpharmatis shall provide full regulatory support over the whole life cycle of your product.

On October 30, 2017, Inpharmatis signed the contract  no. SKV-L-2017/535 with Latvian Investment and Development Agency for funding under the “International competitiveness promotion” measures, co-financed by the European Regional Development Fund.

Inpharmatis has been audited and found to meet the requirements of standard ISO 9001:2015 Quality Management System.